Copyright Reports & Markets. All rights reserved.

Global Orthopaedic Oncology Professional Survey Report 2020, Forecast to 2025

Buy now

Table of Contents

    Global Orthopaedic Oncology Professional Survey Report Report 2020, Forecast to 2025

      1 Market Overview

      • 1.1 Orthopaedic Oncology Definition
        • 1.1.1 Analysis of Macroeconomic Indicators
        • 1.1.2 Years Considered
      • 1.2 Orthopaedic Oncology Segment by Type
        • 1.2.1 Surgery
        • 1.2.2 Chemotherapy
        • 1.2.3 Radiation Therapy
        • 1.2.4 Targeted Therapy
      • 1.3 Market Analysis by Application
        • 1.3.1 Hospitals
        • 1.3.2 Research Laboratories
      • 1.4 Global Orthopaedic Oncology Market Comparison by Regions (2020-2025)
        • 1.4.1 Global Orthopaedic Oncology Market Size (2015-2025)
        • 1.4.2 North America Orthopaedic Oncology Status and Prospect (2015-2025)
        • 1.4.3 Europe Orthopaedic Oncology Status and Prospect (2015-2025)
        • 1.4.4 Asia-Pacific Orthopaedic Oncology Status and Prospect (2015-2025)
        • 1.4.5 South America Orthopaedic Oncology Status and Prospect (2015-2025)
        • 1.4.6 Middle East & Africa Orthopaedic Oncology Status and Prospect (2015-2025)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force
        • 1.5.4 Porter's Five Forces Analysis
        • 1.5.5 SWOT Analysis
      • 1.6 Coronavirus Disease 2019 (Covid-19): Orthopaedic Oncology Industry Impact
        • 1.6.1 How the Covid-19 is Affecting the Orthopaedic Oncology Industry
        • 1.6.2 Orthopaedic Oncology Business Impact Assessment - Covid-19
        • 1.6.3 Market Trends and Orthopaedic Oncology Potential Opportunities in the COVID-19 Landscape
        • 1.6.4 Measures / Proposal against Covid-19

      2 Global Orthopaedic Oncology Market Competition by Manufacturer

      • 2.1 Global Orthopaedic Oncology Sales and Market Share by Manufacturer (2018-2020)
      • 2.2 Global Orthopaedic Oncology Revenue and Market Share by Manufacturer (2018-2020)
      • 2.3 Global Orthopaedic Oncology Industry Concentration Ratio (CR5 and HHI)
      • 2.4 Top 5 Orthopaedic Oncology Manufacturer Market Share
      • 2.5 Top 10 Orthopaedic Oncology Manufacturer Market Share
      • 2.6 Date of Key Manufacturers Enter into Orthopaedic Oncology Market
      • 2.7 Key Manufacturers Orthopaedic Oncology Product Offered
      • 2.8 Mergers & Acquisitions Planning

      3 Analysis of Orthopaedic Oncology Industry Key Manufacturers

      • 3.1 Stryker Corporation
        • 3.1.1 Company Details
        • 3.1.2 Product Information
        • 3.1.3 Stryker Corporation Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.1.4 Main Business Overview
        • 3.1.5 Stryker Corporation News
      • 3.2 F. Hoffmann-La Roche Ltd.
        • 3.2.1 Company Details
        • 3.2.2 Product Information
        • 3.2.3 F. Hoffmann-La Roche Ltd. Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.2.4 Main Business Overview
        • 3.2.5 F. Hoffmann-La Roche Ltd. News
      • 3.3 Accentus Inc.
        • 3.3.1 Company Details
        • 3.3.2 Product Information
        • 3.3.3 Accentus Inc. Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.3.4 Main Business Overview
        • 3.3.5 Accentus Inc. News
      • 3.4 Amgen Inc.
        • 3.4.1 Company Details
        • 3.4.2 Product Information
        • 3.4.3 Amgen Inc. Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.4.4 Main Business Overview
        • 3.4.5 Amgen Inc. News
      • 3.5 MD Anderson Cancer Center
        • 3.5.1 Company Details
        • 3.5.2 Product Information
        • 3.5.3 MD Anderson Cancer Center Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.5.4 Main Business Overview
        • 3.5.5 MD Anderson Cancer Center News
      • 3.6 Creganna Medical Group
        • 3.6.1 Company Details
        • 3.6.2 Product Information
        • 3.6.3 Creganna Medical Group Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.6.4 Main Business Overview
        • 3.6.5 Creganna Medical Group News
      • 3.7 Sanofi S.A.
        • 3.7.1 Company Details
        • 3.7.2 Product Information
        • 3.7.3 Sanofi S.A. Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.7.4 Main Business Overview
        • 3.7.5 Sanofi S.A. News
      • 3.8 Siemens Healthineers
        • 3.8.1 Company Details
        • 3.8.2 Product Information
        • 3.8.3 Siemens Healthineers Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.8.4 Main Business Overview
        • 3.8.5 Siemens Healthineers News
      • 3.9 Canon Medical Systems
        • 3.9.1 Company Details
        • 3.9.2 Product Information
        • 3.9.3 Canon Medical Systems Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.9.4 Main Business Overview
        • 3.9.5 Canon Medical Systems News
      • 3.10 Novartis AG
        • 3.10.1 Company Details
        • 3.10.2 Product Information
        • 3.10.3 Novartis AG Orthopaedic Oncology Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.10.4 Main Business Overview
        • 3.10.5 Novartis AG News

      4 Global Orthopaedic Oncology Market Size Categorized by Regions

      • 4.1 Global Orthopaedic Oncology Revenue, Sales and Market Share by Regions
        • 4.1.1 Global Orthopaedic Oncology Sales and Market Share by Regions (2015-2020)
        • 4.1.2 Global Orthopaedic Oncology Revenue and Market Share by Regions (2015-2020)
      • 4.2 North America Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 4.3 Europe Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 4.4 Asia-Pacific Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 4.5 South America Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 4.6 Middle East & Africa Orthopaedic Oncology Sales and Growth Rate (2015-2020)

      5 North America Orthopaedic Oncology Market Size Categorized by Countries

      • 5.1 North America Orthopaedic Oncology Sales, Revenue and Market Share by Countries
        • 5.1.1 North America Orthopaedic Oncology Sales by Countries (2015-2020)
        • 5.1.2 North America Orthopaedic Oncology Revenue by Countries (2015-2020)
        • 5.1.3 United States Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 5.1.4 Canada Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 5.1.5 Mexico Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 5.2 North America Orthopaedic Oncology Revenue (Value) by Manufacturers (2018-2020)
      • 5.3 North America Orthopaedic Oncology Sales, Revenue and Market Share by Type (2015-2020)
        • 5.3.1 North America Orthopaedic Oncology Sales Market Share by Type (2015-2020)
        • 5.3.2 North America Orthopaedic Oncology Revenue and Revenue Share by Type (2015-2020)
      • 5.4 North America Orthopaedic Oncology Sales Market Share by Application (2015-2020)

      6 Europe Orthopaedic Oncology Market Size Categorized by Countries

      • 6.1 Europe Orthopaedic Oncology Sales, Revenue and Market Share by Countries
        • 6.1.1 Europe Orthopaedic Oncology Sales by Countries (2015-2020)
        • 6.1.2 Europe Orthopaedic Oncology Revenue by Countries (2015-2020)
        • 6.1.3 Germany Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 6.1.4 UK Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 6.1.5 France Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 6.1.6 Russia Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 6.1.7 Italy Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 6.1.8 Spain Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 6.2 Europe Orthopaedic Oncology Revenue (Value) by Manufacturers (2018-2020)
      • 6.3 Europe Orthopaedic Oncology Sales, Revenue and Market Share by Type (2015-2020)
        • 6.3.1 Europe Orthopaedic Oncology Sales Market Share by Type (2015-2020)
        • 6.3.2 Europe Orthopaedic Oncology Revenue and Revenue Share by Type (2015-2020)
      • 6.4 Europe Orthopaedic Oncology Sales Market Share by Application (2015-2020)

      7 Asia-Pacific Orthopaedic Oncology Market Size Categorized by Countries

      • 7.1 Asia-Pacific Orthopaedic Oncology Sales, Revenue and Market Share by Countries
        • 7.1.1 Asia-Pacific Orthopaedic Oncology Sales by Countries (2015-2020)
        • 7.1.2 Asia-Pacific Orthopaedic Oncology Revenue by Countries (2015-2020)
        • 7.1.3 China Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 7.1.4 Japan Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 7.1.5 Korea Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 7.1.6 India Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 7.1.7 Southeast Asia Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 7.1.8 Australia Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 7.2 Asia-Pacific Orthopaedic Oncology Sales and Revenue (Value) by Manufacturers (2018-2020)
      • 7.3 Asia-Pacific Orthopaedic Oncology Sales, Revenue and Market Share by Type (2015-2020)
        • 7.3.1 Asia-Pacific Orthopaedic Oncology Sales Market Share by Type (2015-2020)
        • 7.3.2 Asia-Pacific Orthopaedic Oncology Revenue and Revenue Share by Type (2015-2020)
      • 7.4 Asia-Pacific Orthopaedic Oncology Sales and Market Share by Application (2015-2020)

      8 South America Orthopaedic Oncology Market Size Categorized by Countries

      • 8.1 South America Orthopaedic Oncology Sales, Revenue and Market Share by Countries
        • 8.1.1 South America Orthopaedic Oncology Sales by Countries (2015-2020)
        • 8.1.2 South America Orthopaedic Oncology Revenue by Countries (2015-2020)
        • 8.1.3 Brazil Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 8.2 South America Orthopaedic Oncology Revenue (Value) by Manufacturers (2018-2020)
      • 8.3 South America Orthopaedic Oncology Sales, Revenue and Market Share by Type (2015-2020)
        • 8.3.1 South America Orthopaedic Oncology Sales Market Share by Type (2015-2020)
        • 8.3.2 South America Orthopaedic Oncology Revenue and Revenue Share by Type (2015-2020)
      • 8.4 South America Orthopaedic Oncology Sales Market Share by Application (2015-2020)

      9 Middle East and Africa Orthopaedic Oncology Market Size Categorized by Countries

      • 9.1 Middle East and Africa Orthopaedic Oncology Sales, Revenue and Market Share by Countries
        • 9.1.1 Middle East and Africa Orthopaedic Oncology Sales by Countries (2015-2020)
        • 9.1.2 Middle East and Africa Orthopaedic Oncology Revenue by Countries (2015-2020)
        • 9.1.3 GCC Countries Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 9.1.4 Turkey Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 9.1.5 Egypt Orthopaedic Oncology Sales and Growth Rate (2015-2020)
        • 9.1.6 South Africa Orthopaedic Oncology Sales and Growth Rate (2015-2020)
      • 9.2 Middle East and Africa Orthopaedic Oncology Revenue (Value) by Manufacturers (2018-2020)
      • 9.3 Middle East and Africa Orthopaedic Oncology Sales, Revenue and Market Share by Type
        • 9.3.1 Middle East and Africa Orthopaedic Oncology Sales Market Share by Type (2015-2020)
        • 9.3.2 Middle East and Africa Orthopaedic Oncology Revenue and Revenue Share by Type (2015-2020)
      • 9.4 Middle East and Africa Orthopaedic Oncology Sales Market Share by Application (2015-2020)

      10 Global Orthopaedic Oncology Market Segment by Type

      • 10.1 Global Orthopaedic Oncology Revenue, Sales and Market Share by Type (2015-2020)
        • 10.1.1 Global Orthopaedic Oncology Sales and Market Share by Type (2015-2020)
        • 10.1.2 Global Orthopaedic Oncology Revenue and Market Share by Type (2015-2020)
      • 10.2 Surgery Sales Growth Rate and Price
        • 10.2.1 Global Surgery Sales Growth Rate (2015-2020)
        • 10.2.2 Global Surgery Price
      • 10.3 Chemotherapy Sales Growth Rate and Price
        • 10.3.1 Global Chemotherapy Sales Growth Rate (2015-2020)
        • 10.3.2 Global Chemotherapy Price
      • 10.4 Radiation Therapy Sales Growth Rate and Price
        • 10.4.1 Global Radiation Therapy Sales Growth Rate (2015-2020)
        • 10.4.2 Global Radiation Therapy Price
      • 10.5 Targeted Therapy Sales Growth Rate and Price
        • 10.5.1 Global Targeted Therapy Sales Growth Rate (2015-2020)
        • 10.5.2 Global Targeted Therapy Price

      11 Global Orthopaedic Oncology Market Segment by Application

      • 11.1 Global Orthopaedic OncologySales Market Share by Application (2015-2020)
      • 11.2 Hospitals Sales Growth Rate (2015-2020)
      • 11.3 Research Laboratories Sales Growth Rate (2015-2020)

      12 Market Forecast for Orthopaedic Oncology

      • 12.1 Global Orthopaedic Oncology Revenue, Sales and Growth Rate (2020-2025)
      • 12.2 Orthopaedic Oncology Market Forecast by Regions (2020-2025)
        • 12.2.1 North America Orthopaedic Oncology Market Forecast (2020-2025)
        • 12.2.2 Europe Orthopaedic Oncology Market Forecast (2020-2025)
        • 12.2.3 Asia-Pacific Orthopaedic Oncology Market Forecast (2020-2025)
        • 12.2.4 South America Orthopaedic Oncology Market Forecast (2020-2025)
        • 12.2.5 Middle East & Africa Orthopaedic Oncology Market Forecast (2020-2025)
      • 12.3 Orthopaedic Oncology Market Forecast by Type (2020-2025)
        • 12.3.1 Global Orthopaedic Oncology Sales Forecast by Type (2020-2025)
        • 12.3.2 Global Orthopaedic Oncology Market Share Forecast by Type (2020-2025)
      • 12.4 Orthopaedic Oncology Market Forecast by Application (2020-2025)
        • 12.4.1 Global Orthopaedic Oncology Sales Forecast by Application (2020-2025)
        • 12.4.2 Global Orthopaedic Oncology Market Share Forecast by Application (2020-2025)

      13 Orthopaedic Oncology Related Market Analysis

      • 13.1 Upstream Analysis
        • 13.1.1 Macro Analysis of Upstream Markets
        • 13.1.2 Key Players in Upstream Markets
        • 13.1.3 Upstream Market Trend Analysis
        • 13.1.4 Manufacturing Cost Analysis
      • 13.2 Downstream Market Analysis
        • 13.2.1 Macro Analysis of Down Markets
        • 13.2.2 Key Players in Down Markets
        • 13.2.3 Downstream Market Trend Analysis
        • 13.2.4 Sales Channel, Distributors, Traders and Dealers

      14 Research Findings and Conclusion

        15 Appendix

        The report forecast global Orthopaedic Oncology market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period of 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. Estimates of the regional markets for Orthopaedic Oncology are based on the applications market.

        The report demonstrates detail coverage of Orthopaedic Oncology industry and main market trends.
        The market research includes historical and forecast data, like demand, application details, price trends, and company shares of the leading Orthopaedic Oncology by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
        Since the COVID-19 virus outbreak in December 2019, the World Health Organization declared it a public health emergency. The desease has spread to over 100 countries and caused huge losses of lives around the globe. Especially the global manufacturing, tourism and financial markets have been hit hard. The downward pressure on the world economy that once showed signs of recovery in the previous period has increased again. The outbreak of the epidemic has added risk factors to the already weak growth of the world economy. Many international organizations have pointed out that the world economy is in the most severe period since the financial crisis.
        The negative global impacts of the coronavirus are already there, significantly affecting the Orthopaedic Oncology market in 2020. This report studies and analyzes the in-depth impact of Coronavirus COVID-19 on the Orthopaedic Oncology industry.
        In addition, the report provides insight into main drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Orthopaedic Oncology market are discussed. And this report covers the historical situation, present status and the future prospects of the global Orthopaedic Oncology market for 2015-2025.

        Market Segment by Product Type
        Surgery
        Chemotherapy
        Radiation Therapy
        Targeted Therapy

        Market Segment by Product Application
        Hospitals
        Research Laboratories

        Finally, the report provides detailed profile and data information analysis of leading company.
        Stryker Corporation
        F. Hoffmann-La Roche Ltd.
        Accentus Inc.
        Amgen Inc.
        MD Anderson Cancer Center
        Creganna Medical Group
        Sanofi S.A.
        Siemens Healthineers
        Canon Medical Systems
        Novartis AG

        Report Includes:
        - xx data tables (appendix tables)
        - Overview of global Orthopaedic Oncology market
        - An detailed key players analysis across regions
        - Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
        - Insights into regulatory and environmental developments
        - Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Orthopaedic Oncology market
        - Profiles of major players in the industry, including Stryker Corporation, F. Hoffmann-La Roche Ltd., Accentus Inc., Amgen Inc., MD Anderson Cancer Center.....

        Research Objectives
        1.To study and analyze the global Orthopaedic Oncology consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
        2.To understand the structure of Orthopaedic Oncology market by identifying its various subsegments.
        3.Focuses on the key global Orthopaedic Oncology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
        4.To analyze the Orthopaedic Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.
        5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        6.To project the consumption of Orthopaedic Oncology submarkets, with respect to key regions (along with their respective key countries).
        7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        8.To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now